A Study to Evaluate the Safety, Pharmacokinetics, and Pharmacodynamics of JNJ-42756493 in Adult Participants With Advanced or Refractory Solid Tumors or Lymphoma
Janssen Research & Development, LLC
Janssen Research & Development, LLC
Cyteir Therapeutics, Inc.
Fate Therapeutics
Opna Bio LLC
Novartis
Institut Bergonié
Incyte Corporation
Celgene
University of Wisconsin, Madison
AbbVie
Amgen
Novartis
INSYS Therapeutics Inc
National Cancer Institute (NCI)
National Cancer Institute (NCI)
Novartis
National Institutes of Health Clinical Center (CC)
National Institutes of Health Clinical Center (CC)
University of Utah
Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
Case Comprehensive Cancer Center